about
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinomaPhosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitisRegulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Discovery of new G protein-coupled receptors for lipid mediators.Lysophospholipids in development: Miles apart and edging in.Fibroblastic reticular cell-derived lysophosphatidic acid regulates confined intranodal T-cell motility.A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells.Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells.Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor.Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.Spinal cord compression injury in lysophosphatidic acid 1 receptor-null mice promotes maladaptive pronociceptive descending control.Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acidAnaplasma phagocytophilum Manipulates Host Cell Apoptosis by Different Mechanisms to Establish Infection.LPA2 receptor mediates mitogenic signals in human colon cancer cells.Endogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression
P2860
Q24796051-B168BCAB-9BC8-4EE3-A898-877F0FB4C9A1Q34227743-E9CA4E06-7419-4978-BB36-B92257CF01A2Q34645463-E49EE3F6-C8CD-43F4-AC9E-23833C0A8E40Q35551835-BDC98D22-8107-432B-80BE-BE45ABA5AD1AQ35600796-6295D61D-62DB-4459-9625-15E688ED9A7EQ35839033-18E9E7B9-4F2A-432A-A533-57E9EAC73BC4Q36585912-33BD4D51-A9C3-44FD-90A7-B46CA5363B7CQ36960355-9518CA95-54E9-4DCB-A0B8-0A238BAFBCA0Q37215096-6EACCD57-2CE6-4E68-8BED-AC3199AC8B47Q39427075-9CAB75ED-7EEC-4AC7-9753-E50ABDFBC5E7Q40366649-F7F46564-3689-4AFA-8FDC-C33471CE86A6Q40457161-C33CA0F7-C0A7-45FC-83A4-63C0E9FBC529Q40470278-E83D58CE-2701-4279-BB2F-A1C2C46555EEQ40541052-928B811A-5568-499F-B018-FAA87EA2067BQ41144197-F8E92108-F430-40E6-8B64-A90D64EF154BQ41887380-75F7CBE7-86F0-40E0-9394-E7243B7D681BQ42410865-2A46A0ED-5B25-46B1-A5B5-2A66C1D7BD66Q43173614-73E3DD3D-73C3-4B59-ADD1-4B4BF976743DQ45281003-97B984DF-0077-48ED-9EEA-194079A2C12BQ57375107-44DFA396-2D0B-4853-B7A1-9F0CB391DB01
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lysophospholipid mediators of immunity and neoplasia.
@ast
Lysophospholipid mediators of immunity and neoplasia.
@en
Lysophospholipid mediators of immunity and neoplasia.
@nl
type
label
Lysophospholipid mediators of immunity and neoplasia.
@ast
Lysophospholipid mediators of immunity and neoplasia.
@en
Lysophospholipid mediators of immunity and neoplasia.
@nl
prefLabel
Lysophospholipid mediators of immunity and neoplasia.
@ast
Lysophospholipid mediators of immunity and neoplasia.
@en
Lysophospholipid mediators of immunity and neoplasia.
@nl
P2093
P1476
Lysophospholipid mediators of immunity and neoplasia.
@en
P2093
Edward J Goetzl
Geetha Shankar
Juliet Spencer
Markus Graeler
Mei Chuan Huang
P304
P356
10.1016/S1388-1981(02)00151-8
P407
P577
2002-05-01T00:00:00Z